References
- Husby G, Marhaug G, Dowton B, Sletten K, Sipe J D. Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis. Amyloid: Int J Exp Clin Invest 1994; 1: 119–137
- Liepnieks J J, Kluve-Beckerman B, Benson M D. Characterization of amyloid A protein in human secondary amyloidosis. The predominant deposition of serum amyloid Al. Biochim Biophys Acta 1995; 1270: 81–86
- Baba S, Masago S A, Takahashi T, Kasama T, Sugimura H, Tsugane S, Tsutsui Y, Shirasawa H. A novel alleic variant of serum amyloid A. SAA1g: Genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic amyloidosis. Hum Mol Genet 1995; 4: 1083–1087
- Booth D R, Booth S E, Gillmore J D, Hawkins P N, Pepys M B. SAA1 alleles as risk factors in reactive systemic amyloidosis. Amyloid. Int J Exp Clin Invest 1998; 5: 262–265
- Sipe J D. Revised nomenclature for serum amyloid A (SAA). Amyloid. Int J Exp Clin Invest 1999; 6: 67–70, and Com mittee
- Betts J C, Edbrooke M R, Thakker R V, Woo P. The human acute-phase serum amyloid A gene family: structure, evolution and expression in hepatoma cells. Scand J Immunol 1991; 34: 471–482
- Beach C M, deBeer M C, Sipe J D, Loose L D, deBeer F C. Human serum amyloid A protein. Complete amino acid sequence of a new variant. Biochem J 1992; 282: 615–620
- Yamada T, Wada A, Itoh Y, Itoh K. 1999, Serum amyloid Al alleles and plasma SAA concentration. Amyloid: Int J Exp Clin Invest in press
- Westermark P, Sletten K, Westermark G T, Raynes J, McAdam K PWJ. A protein AA-variant derived from a novel serum AA protein, SAA Id, in an individual from Papua New Guinea. Biochem Biophys Res Commun 1996; 223: 320–323